CompoAtlas

Mantra sennosides 8,6 mg

Natural health product licensed in Canada

Licence holder
Mantra Pharma Inc.
NPN or DIN-HM
80055640
Status
Inactive licence
Licence date
14 November 2014
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Senna alexandrina

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 40:1

Dry plant equivalent : 590.4 mg

Potency : 8.6 mg Sennosides

14.76 mgNot calculated

Non-medicinal ingredients

Carboxyméthylcellulose de sodium, Gel de silice colloïdal, Jaune FD&C no 6, cellulose, Amidon prégélatinisé, Lauryl sulfate de sodium, Macrogol, Stéarate de magnésium, Laque d'aluminiium FD&C rouge n° 40, Poly(alcool vinylique), Talc, Dioxyde de titane, Laque d'aluminium bleu FD&C No 2

PopulationAgeQuantity per servingFrequency
Adultes et adolescentsminimum: 11 yearsminimum: 2 Comprimé ; maximum: 3 Comprimé1 Tous les jours

Uses authorised in Canada

Utilisée en phytothérapie pour le soulagement à court-terme de la constipation occasionnelle. Utilisée traditionnellement en phytothérapie comme laxatif stimulant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80055640

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Senna alexandrina
    Read the warning, when it applies and the studies cited

    SENNA - SENNA ALEXANDRINA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000; WHO 1999).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000; WHO 1999).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant or breastfeeding (EMA 2018a,b; Brinker 2010; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2018a,b; Gardner and McGuffin 2013; Brinker 2010; WHO 1999).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy or diarrhoea occurs (EMA 2018a,b; Blumenthal et al. 2000; WHO 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line